UK4 is a biological drug substance manufacturing facility that was designed and built under a “Three Zeros for Sustainable Development” concept. The three zeros encompass: 1) zero halogenated hydrocarbons, 2) zero natural gas, and 3) zero CO2 (in non-GMP areas)
This new 40,000-square foot facility was specifically designed for the manufacture of early-stage investigational medicinal products. It consists of a four-floor production building with office space and material storage on the first floor, manufacturing areas on the second and third floors, and utilities on the fourth floor and roof. The culture room houses 50, 500, and 2000 liters of single-use bioreactors and has two 2000 liters of production-scale single-use bioreactors.
Chugai Pharma Manufacturing Co., Ltd. is recognized as the 2024 ISPE FOYA Category Winner for Social Impact, Sustainability.
